Hormone Drugs Make $6.3 Billion Comeback After FDA Nixes Safety Warnings - Bloomberg.com

Hormone Drugs Make $6.3 Billion Comeback After FDA Nixes Safety Warnings  Bloomberg.comOpinion | Hormones Don’t Need to Make You Live Longer to Be Worth It  The New York TimesEstrogen patches face shortage as more women seek hormone therapy  PBSHormone replacement therapy (HRT): risks, benefits and choices  Pharmacy MagazineMany women who rely on an estrogen patch are struggling to have their prescriptions filled  KCLU